Journal of Clinical Virology
Volume 46, Issue 4 , Pages 318-324, December 2009

Incidence, molecular epidemiology and clinical presentations of human metapneumovirus; assessment of its importance as a diagnostic screening target

  • Eleanor Gaunt

      Affiliations

    • Centre for Infectious Diseases, University of Edinburgh, Summerhall, Edinburgh EH9 1QH, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 131 650 7945; fax: +44 131 650 6511.
  • ,
  • E. Carol McWilliam-Leitch

      Affiliations

    • Centre for Infectious Diseases, University of Edinburgh, Summerhall, Edinburgh EH9 1QH, United Kingdom
  • ,
  • Kate Templeton

      Affiliations

    • Department of Virology, Royal Infirmary of Edinburgh, 51 Little France Crescent, Old Dalkeith Road, Edinburgh EH16 4SA, United Kingdom
  • ,
  • Peter Simmonds

      Affiliations

    • Centre for Infectious Diseases, University of Edinburgh, Summerhall, Edinburgh EH9 1QH, United Kingdom

Received 22 May 2009; received in revised form 8 September 2009; accepted 11 September 2009. published online 12 October 2009.

Abstract 

Background

Human metapneumovirus (HMPV) is a recently discovered human paramyxovirus associated with a spectrum of respiratory symptoms from the common cold to pneumonia and bronchiolitis.

Objectives

To assess the clinical significance and epidemiology of HMPV, standardized comparison of frequencies of infection, age profiles and disease associations were made with other respiratory viruses in Scotland.

Study design

7091 respiratory samples collected in Scotland between 1 July 2006 and 30 June 2008 from 4282 individuals were screened by multiplex RT-PCR for respiratory syncytial virus (HRSV), adenovirus (AdV), parainfluenzaviruses 1–3 (PIV-1, -2 and -3), influenza A and B and by nested RT-PCR for HMPV.

Results

HMPV was the fifth most prevalent virus (2.0% of samples), found predominantly in young children in winter months. In the 2006–2007 respiratory season, 70% of HMPV isolates were genotype A, but a switch to predominantly type B infections occurred next winter. For samples with information on clinical presentations, 26% of HMPV infections were from subjects with lower respiratory tract presentations, lower than recorded for HRSV, but similar to adenovirus, parainfluenza viruses and influenza viruses A and B. Around 13% of HMPV infections were associated with upper respiratory tract symptoms or disease, comparable with other respiratory virus infections.

Conclusions

Numerically and through its association with respiratory disease, HMPV represents a diagnostically significant target that should be included in PCR-based routine screening of respiratory samples. Understanding the biological basis of observed rapid turnover of HMPV variants, including the observed HMPV genotype change between respiratory seasons requires further longitudinal studies.

Keywords: Human metapneumovirus, Molecular epidemiology, Genotype, Respiratory syncytial virus, Molecular diagnostics

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1386-6532(09)00432-6

doi:10.1016/j.jcv.2009.09.016

Journal of Clinical Virology
Volume 46, Issue 4 , Pages 318-324, December 2009